dexamethasone,lenalidomide,carfilzomib
amgen
['mmsm', 'atlas']
a new map for maintenance? atlas: krd (response adapted) vs r maint post asct. pfs 59 m vs 41 m. tox comparable. mrd-adapted results still favor krd. as usual more drugs=better but maybe a pathway to limit duration of tx for some? #mmsm #asco2022 